OTC · Financial Statements
BioLargo, Inc. (BLGO) Financial Statements
$0.10
OTC: BLGO
Market Cap $33.37M
Overview Financials Dividend
BioLargo, Inc. most recently reported annual revenue of $8.0M, a net loss of $12.0M. Revenue grew at an average annual rate of 32.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $3.0M $6.0M $12.0M $18.0M $8.0M Operating Profit $-6.0M $-5.0M $-4.0M $-4.0M $-15.0M Net Profit $-7.0M $-4.0M $-4.0M $-2.0M $-12.0M EPS $-0.03 $-0.02 $-0.01 $-0.01 $-0.04 Op Margin -252.1% -87.0% -34.2% -24.4% -191.1%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $3.0M $5.0M $8.0M $11.0M $8.0M Total Liabilities $2.0M $3.0M $4.0M $4.0M $7.0M Cash $1.0M $2.0M $4.0M $4.0M $4.0M Borrowings $1.0M $1.0M $2.0M $3.0M $4.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $-4.0M $-3.0M $-2.0M $-3.0M $-8.0M Investing Cash Flow $0 $-1.0M $-1.0M $-3.0M $0 Financing Cash Flow $4.0M $4.0M $5.0M $1.0M $0 Net Cash Flow $0 $1.0M $2.0M $0 $0 Free Cash Flow $-4.0M $-3.0M $-3.0M $-4.0M $-8.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.02 EV / EBITDA -2.20 FCF Yield -28.35% Quick Ratio 1.04 Interest Coverage -23.62 Return 1Y -38.82% Return 3Y -42.22% Return 5Y -50.48%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .